Thousands of lives could be saved thanks to a new heart drug hailed as the biggest breakthrough since statins.
In a landmark four-year trial, scientists found that the drug – given by injection every three months – cut the risk of heart attacks by a quarter.
The 10,000-patient study, involving 1,000 doctors in 39 countries, also suggested it could halve the risk of dying from lung cancer and prevent arthritis and gout.
Scientists last night said the treatment marked ‘a new era of therapeutics’ that could save thousands of lives.
The drug, Canakinumab, works by reducing inflammation – a major new approach in heart medicine.